Publication & Citation Trends
Publications
0 total
Increased Rates of MRD Conversion from Positive (+ve) to Negative (-ve) Following ASCT Compared to Chemotherapy Consolidation in Newly Diagnosed Multiple Myeloma Is Prognostic for Improved Progression Free Survival: Dynamic MRD Assessment in the UK-MRA Cardamon Trial
Cited by 0
Semantic Scholar
The XPO1-FOXC1-HOX Functional Axis Opens New Therapeutic Avenues to Treat DEK-NUP214 AML Patients OA
Cited by 0
Semantic Scholar
Ixazomib-Based Consolidation and Maintenance Prolongs Progression-Free Survival after Salvage Autologous Stem Cell Transplantation (sASCT): Results from Interim Analysis of UK-MRA Myeloma XII (ACCoRD) OA
Cited by 0
Semantic Scholar
High Neoantigen Load Confers a Major Benefit from Autologous Stem Cell Transplantation Compared to Consolidation in Newly Diagnosed Multiple Myeloma OA
Cited by 0
Semantic Scholar
P-390 The differentiation and expansion of T cell clonotypes in the bone marrow following ASCT: insights from the Phase 2 CARDAMON study
Cited by 0
Semantic Scholar
Machine learning from the CARDAMON trial identifies a carfilzomib-specific mutational response signature OA
Cited by 0
Semantic Scholar
Carfilzomib, Cyclophosphamide and Dexamethasone (KCD) Versus Bortezomib, Cyclophosphamide and Dexamethasone (VCD) for Treatment of First Relapse or Primary Refractory Multiple Myeloma (MM): First Final Analysis of the Phase 2 Muk Five Study
Cited by 9
Semantic Scholar
A phase I/II study of KW-2478, an Hsp90 inhibitor, in combination with bortezomib in patients with relapsed/refractory multiple myeloma OA
Cited by 55
Semantic Scholar
Research Topics
Multiple Myeloma Research and Treatments
(102)
Acute Myeloid Leukemia Research
(78)
Protein Degradation and Inhibitors
(54)
Hematopoietic Stem Cell Transplantation
(39)
Acute Lymphoblastic Leukemia research
(23)
Affiliations
National Health Service
Novartis (Switzerland)
St Bartholomew's Hospital
St George's Hospital
University of Ulster